CLINICAL_TRIALS
trial_result
· 2013-08-15
Clinical Trial Update: Study of E7389 for Advanced or Metastatic Breast Cancer [Phase 2]
Summary
A Phase 2 study of E7389 (eribulin) for advanced or metastatic breast cancer has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-15